Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma.
about
Neurofibromatosis type 2 (NF2): a clinical and molecular reviewGlobal profiling in vestibular schwannomas shows critical deregulation of microRNAs and upregulation in those included in chromosomal region 14q32.Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation.The molecular biology of vestibular schwannomas and its association with hearing loss: a review.Genetic and epigenetic alterations of the NF2 gene in sporadic vestibular schwannomas.Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms.Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.Differential NF2 Gene Status in Sporadic Vestibular Schwannomas and its Prognostic Impact on Tumour Growth PatternsA role for epigenetics in hearing: Establishment and maintenance of auditory specific gene expression patterns.Global expression profile in low grade meningiomas and schwannomas shows upregulation of PDGFD, CDH1 and SLIT2 compared to their healthy tissue.The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapyRole of Merlin/NF2 inactivation in tumor biology.Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling.Predictors of the risk of mortality in neurofibromatosis 2Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II].The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.Epigenetic regulation of self-renewal and fate determination in neural stem cells.Merlin: the wizard requires protein stability to function as a tumor suppressor.Schwannomas and their pathogenesis.Valproate induces replication-independent active DNA demethylation.Expression analysis of tumor-related genes involved in critical regulatory pathways in schwannomas.Lack of neurofibromatosis type 2 gene promoter methylation in sporadic vestibular schwannomas.[Pathogenesis and molecular pathology of vestibular schwannoma].Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomas.Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas
P2860
Q21202892-106E732F-177C-4EEB-A628-FF31C436F389Q30453465-2E67223B-C548-4D86-9C66-B562445DEA10Q30456266-48CCD2FC-9ED4-4D5A-97A8-E41C994C9E39Q30467803-75125E2A-9B04-4828-B664-1C7E05BD686AQ30471127-C23C3662-2038-455F-9870-979719B9C366Q30493825-306C9514-5848-46BB-B160-CFEE9164AF73Q33269178-7B2FEF5B-E143-4E2C-A121-4BFF5D4B2599Q33906075-BC287F5B-79A4-4F36-BB3A-D221A0D37406Q34363956-8CC73995-5958-45F7-8304-36419DC28119Q34556785-B4C01C06-778D-4FF5-A667-432C2036EAD7Q35847845-C152378A-EFC7-42DA-B02A-8EE18B12E399Q36189820-EF663551-BE29-4BD5-84BA-B8D9418B770BQ36296784-1D288D31-E600-4607-A409-1C168ED2880EQ37202827-1DA9F77B-A4AC-4761-8387-7175B0EA4842Q37571402-815BD4B0-14DC-4765-BFA9-0F56B7921069Q37601480-B3E8E92A-497F-4423-AB23-74AB8A3D12E8Q37970038-ED8F4174-78A1-4237-B42A-ED5425C76507Q38023101-ED0B6E9B-A711-42CF-BFD1-9FE55F7E9470Q38180808-F3F8BAC7-0F26-410D-BA21-81CEB3A24002Q40647716-492F7628-F9A9-4B7D-B7E2-132BBDC99B43Q43502413-9C5F4676-9BA2-43BD-96A1-64246B7FACDDQ45922601-F3370C87-93BC-4820-B46A-0DE94C579419Q52991168-84B4831C-70AF-4832-B8DF-989A7E30E0C7Q54466787-25A73CF3-C030-4135-BED4-B370E4E995A8Q57207010-416DB2EE-275A-4D3B-8CC3-70ADBDD7BECA
P2860
Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Identification of the cis-acti ...... ndent silencing in schwannoma.
@en
Identification of the cis-acti ...... ndent silencing in schwannoma.
@nl
type
label
Identification of the cis-acti ...... ndent silencing in schwannoma.
@en
Identification of the cis-acti ...... ndent silencing in schwannoma.
@nl
prefLabel
Identification of the cis-acti ...... ndent silencing in schwannoma.
@en
Identification of the cis-acti ...... ndent silencing in schwannoma.
@nl
P2093
P2860
P1433
P1476
Identification of the cis-acti ...... ndent silencing in schwannoma.
@en
P2093
Takeshima H
P2860
P304
P356
10.1046/J.1365-2443.2001.00432.X
P577
2001-05-01T00:00:00Z